Evaluation of the Pharmacokinetics of Caspofungin in ICU Patients

Trial Profile

Evaluation of the Pharmacokinetics of Caspofungin in ICU Patients

Recruiting
Phase of Trial: Phase II

Latest Information Update: 14 Nov 2016

At a glance

  • Drugs Caspofungin (Primary)
  • Indications Aspergillosis; Candidaemia; Candidiasis
  • Focus Pharmacokinetics
  • Acronyms CaspoKin
  • Most Recent Events

    • 09 Nov 2016 Planned End Date changed from 1 Sep 2016 to 1 Feb 2018.
    • 09 Nov 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Feb 2018.
    • 10 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top